Ufasomal nanocarriers for enhanced cardiac delivery of nifedipine: a novel strategy to mitigate doxorubicin-induced cardiotoxicity in breast cancer therapy.
- DOI
- 10.1080/1061186x.2026.2729358
- Published
- 2026 Sep 13
- Container
- Journal of drug targeting
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1080/1061186x.2026.2729358,
title = {Ufasomal nanocarriers for enhanced cardiac delivery of nifedipine: a novel strategy to mitigate doxorubicin-induced cardiotoxicity in breast cancer therapy.},
author = {Farouk HO and Abo El-Ela FI and Baali FH and Belal A and Alharbi YN and Alghamdi SSA and Rabea YK and Fouad AG and Hamad DS},
year = {2026},
journal = {Journal of drug targeting},
doi = {10.1080/1061186x.2026.2729358},
url = {https://doi.org/10.1080/1061186x.2026.2729358}
}RIS
TY - JOUR TI - Ufasomal nanocarriers for enhanced cardiac delivery of nifedipine: a novel strategy to mitigate doxorubicin-induced cardiotoxicity in breast cancer therapy. AU - Farouk HO AU - Abo El-Ela FI AU - Baali FH AU - Belal A AU - Alharbi YN AU - Alghamdi SSA AU - Rabea YK AU - Fouad AG AU - Hamad DS PY - 2026 JO - Journal of drug targeting DO - 10.1080/1061186x.2026.2729358 UR - https://doi.org/10.1080/1061186x.2026.2729358 ER -
APA
HO, F., FI, A. E., FH, B., A, B., YN, A., SSA, A., YK, R., AG, F., & DS, H. (2026). Ufasomal nanocarriers for enhanced cardiac delivery of nifedipine: a novel strategy to mitigate doxorubicin-induced cardiotoxicity in breast cancer therapy.. Journal of drug targeting. https://doi.org/10.1080/1061186x.2026.2729358
Source records
- pubmed · retrieved 2026-09-26T14:17:45.199Z